Cerus to present cryoprecipitate comparison study in liver transplantation at 2026 AABB meeting
CERS•Cerus will present transfusion research at the AABB Annual Meeting in Atlanta, Oct. 17-19, 2026, including a comparison of pathogen-reduced and conventional cryoprecipitate in liver transplantation on Oct. 19.
1. Meeting presentations
Cerus will present research on platelet bacterial contamination on Oct. 17 and compare pathogen-reduced with conventional cryoprecipitate in liver transplantation on Oct. 19. An Oct. 18 workshop will examine Grady Health System’s real-world experience implementing INTERCEPT Platelets and INTERCEPT Fibrinogen Complex.
